Novarum™ DX was acquired by BBI Solutions to form part of the BBI Group in October 2016. Recognising that mobile test reader technology will have a significant influence on the diagnostic sector in the next 5 years, BBI Solutions OEM Ltd successfully acquired the remaining shares of its previous joint venture with Novarum.
Novarum’s smartphone diagnostics technology can read and share the results of lateral flow immunoassays which is a form or disposable, rapid test often used within infectious disease, consumer health and over the counter medicine.
BBI Solutions provides comprehensive service solutions, supporting clients with antibody development from sister company MBS, production and characterisation capabilities, robust lateral flow development with signal enhancement, and a patented smartphone diagnostic reader solution. Learn more about BBI Solutions.